Investing Profile
Mark McDade
VCInvestorFounder
Co-Founder and Partner at Qiming Venture Partners USA
qimingvcusa.comSeattle, Washington
Your Intro Paths to Mark McDade
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Mark is a member of
Harvard Business School Network
428 CONNECTIONS
Dartmouth College Network
81 CONNECTIONS
Find Mark McDade on
cbCurrent Investing Position
Qiming Venture Partners USA Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
7
Current Fund Size
$6.2B
Mark McDade is on these Sector & Stage Rankings
Mark McDade's Investments On Record (6)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Icosavax | Series BApr 2021$100M Series AOct 2019$51M  | $150M |
Platelet BioGenesis | Series ASep 2019$26M | $26M |
Talaris Therapeutics | Series AApr 2019$100M | $100M |
WindMIL Therapeutics | Series BJun 2018$33M | $33M |
Twine Health | Series AMay 2017$2M | $2M |
ZappRx | Series BApr 2017$25M | $41M |
Mark McDade's Experience
Co Founder and Partner Qiming Venture Partners USA2017 - Present
EVP and Chief Operating Officer UCB2008 - 2016
CEO PDL BioPharma2002 - 2007
Chief Executive Officer Signature BioScience2001 - 2002
Co-founder and COO Corixa Corporation1994 - 2000
COO Boehringer Mannheim Therapeutics1992 - 1994
Mark McDade's Education
Harvard Business School
Dartmouth College Bachelor of Arts (B.A.) History
Founders who looked at Mark McDade's profile also looked at these Scouts & Angels